Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2022-04-26 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
中泰证券股份有限公司关于内蒙古大唐药业股份有限公司2021年度募集资金存放及使用情况的专项核查报告
Regulatory Filings
2022-04-26 Chinese
2021年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the fiscal year 2021 by Inner Mongolia Datang Pharmaceutical Co., Ltd. It contains detailed descriptions of the company's internal control environment, risk assessment, control activities, information and communication, and internal supervision. It also includes specific evaluation conclusions about the effectiveness of internal controls related to financial reporting and non-financial reporting, with no major deficiencies found. The document is comprehensive, over 7,000 characters, and contains substantive content about internal control evaluation rather than just an announcement or summary. This matches the characteristics of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluation results. It is not an Annual Report (10-K) because it focuses solely on internal control evaluation, not full financial performance. It is not a Regulatory Filing (RNS) because it is a detailed report, not a certification or miscellaneous filing. Therefore, the correct classification is AR with high confidence. FY 2021
2022-04-26 Chinese
独立董事关于第三届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from independent directors regarding several proposals to be submitted to the shareholders' meeting, including profit distribution, audit firm appointment, use of funds, management appointments, and related party transactions. It references the 2021 fiscal year and 2022 plans but does not contain actual financial statements or detailed financial data. The document is a formal opinion on board meeting agenda items, typical of governance or board/management information disclosures. It is not a full annual report, audit report, or earnings release. Given the content focuses on board meeting matters and independent directors' opinions on proposals, the best fitting category is Board/Management Information (MANG). The document length is short (2037 characters), and it is not merely an announcement of a report but an opinion on board matters.
2022-04-26 Chinese
高级管理人员任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management personnel (常务副总经理) at Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the nomination, approval by the board, the appointee's background, and the impact of the appointment on the company. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the appointment. The document is clearly about management changes and not about financial performance or other report types. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (1315 characters), consistent with an announcement rather than a full report.
2022-04-26 Chinese
关于预计2022年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the year 2022. It includes details about the nature of the transactions, the parties involved, board and independent director approvals, and compliance with regulations. The document is relatively short (2721 characters) and focuses on disclosure of anticipated related party transactions rather than presenting financial statements or detailed financial analysis. It does not contain actual financial results or comprehensive financial data. This type of announcement is typical of regulatory filings that disclose material related party transactions to shareholders and the market. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-04-26 Chinese
关于治理专项自查及规范活动相关情况的报告
Governance Information Classification · 95% confidence The document is a detailed report on corporate governance self-inspection and compliance activities by the company, including information on board structure, internal controls, shareholder meetings, and related governance matters. It references company laws, securities laws, and stock exchange listing rules, and provides extensive details on governance mechanisms, board and committee compositions, and compliance with regulations. There is no indication that this is an annual report, audit report, earnings release, or other financial report. Instead, it focuses on governance practices and internal control mechanisms. Therefore, the document fits best under the category of Governance Information (CGR). The document length (5655 characters) and content confirm it is a full report, not just an announcement or certification, so it is not RPA or RNS.
2022-04-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.